CohereNext® Platform, co-designed with physicians, enables health plans and physicians to align on patient care journeys, driving improved quality and safety

BOSTON, Oct. 22, 2020 —Cohere Health, a healthcare collaboration technology company, announced today an agreement with Humana Inc. to improve the prior authorization process for musculoskeletal treatment across 12 states, starting Jan. 1, 2021. Cohere aligns physicians, patients and health plans on a patient’s optimal healthcare experience—enabling access to higher quality care while at the same time minimizing administrative burden and siloed decision-making.

The partnership leverages CohereNext Platform’s prior authorization capability which grants authorizations across an entire episode of care, in effect pre-authorizing a complete treatment regimen from initial diagnosis to treatment plan selection, and, ultimately, to the patient’s return to good health. Cohere’s approach aims to expedite evidence-based treatment plans to improve the healthcare experience for doctors and patients alike.

Humana will employ the CohereNext Platform to streamline prior authorizations in musculoskeletal treatment in Alabama, Georgia, Indiana, Kentucky, Michigan, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Virginia and West Virginia. The platform will initially serve approximately 2 million members and more than 3,500 physician practices.

“Through this strategic initiative and collaboration with Cohere Health, Humana is building on its commitment to reduce the complexity and friction of prior authorization for our physicians and members,” said William Shrank, MD, MSHS, Chief Medical Officer, Humana and Board Member, Cohere Health. “Cohere’s solution was co-designed with physicians and represents a major leap forward in improved physician experience and the adoption of evidence-based medicine.”

This partnership supports Humana’s vision to reimagine and modernize processes for prior authorization by reducing approval times and improving delivery of care, all while preserving important benefits such as safety, predictability and cost containment.

Cohere’s solution will initially focus on prior authorization; the company is developing additional use cases such as value-based contract performance, improving physician and patient engagement, and optimizing health plan clinical programs. By facilitating physician and health plan collaboration, Cohere’s technology will help accelerate the evolution to value-based care models.

“We are pleased to partner with an industry leader and innovator like Humana to reduce the administrative burden on physicians and improve clinical outcomes for its members. Physician and patient transparency is the cornerstone of our approach,” said Siva Namasivayam, CEO, Cohere Health. “Cohere Health is focused on simplifying healthcare’s status quo by addressing barriers to experience, quality and cost. Our platform and solutions are developed with the latest design thinking and technologies with physician and patient-centric perspectives that acknowledges the realities of the variations in individualized care journeys.”

The CohereNext Platform improves the physician experience and quality by:

  • Authorizations that begin with diagnoses and not billing codes
  • Facilitating and auto-approving evidence-based treatment plans
  • Delivering a peer review process with a true peer specialist or sub-specialist
  • Sharing quality performance relative to peers for specific care paths and patient cohorts
  • Providing tools, data and technology that optimizes value-based payment
Published On: October 22nd, 2020Categories: News, Press Release

Share:

About the Author: Cohere Health

Cohere Health is a clinical intelligence company that provides intelligent prior authorization as a springboard to better quality outcomes by aligning physicians and health plans on evidence-based care paths for the patient's entire care journey. Cohere's intelligent prior authorization solutions reduce administrative expenses while improving patient outcomes. The company is a Top 5 LinkedIn™ Startup, winner of the TripleTree iAward, consecutive KLAS Research’s Points of Light recipient, and has been named to both Fierce Healthcare's Fierce 15 and CB Insights' Digital Health 150 lists. Cohere's investors include Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners.